Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Dia Xenaki"'
Autor:
Sandra Rutting, Dia Xenaki, Karosham D. Reddy, Melissa Baraket, David G. Chapman, Gregory G. King, Brian G. Oliver, Katrina O. Tonga
Publikováno v:
ERJ Open Research, Vol 7, Iss 2 (2021)
Externí odkaz:
https://doaj.org/article/1889e3bc570e4ee6927c64fa3217132c
Autor:
Sandra Rutting, Michael Papanicolaou, Dia Xenaki, Lisa G. Wood, Alexander M. Mullin, Philip M. Hansbro, Brian G. Oliver
Publikováno v:
Respiratory Research, Vol 19, Iss 1, Pp 1-12 (2018)
Abstract Background The obesity paradox in COPD describes protective effects of obesity on lung pathology and inflammation. However, the underlying relationships between obesity, diet and disease outcomes in COPD are not fully understood. In this stu
Externí odkaz:
https://doaj.org/article/ab80d8e4f3d047c39ae70d54b797b356
Publikováno v:
ERJ Open Research, Vol 5, Iss 1 (2019)
Externí odkaz:
https://doaj.org/article/46bd71f82c144dceadf37c7a737996d2
Autor:
Philip M. Hansbro, Jay C. Horvat, Lisa Wood, Jack Bozier, Razia Zakarya, Dia Xenaki, Sandra Rutting, Brian G. Oliver
Publikováno v:
American Journal of Respiratory Cell and Molecular Biology. 60:554-568
Obesity is an important risk factor for severe asthma exacerbations, which are mainly caused by respiratory infections. Dietary fatty acids, which are increased systemically in obese patients and are further increased after high-fat meals, affect the
Autor:
Kielan Darcy McAlinden, Dia Xenaki, Saeid Ghavami, Brian G. Oliver, Deepak A. Deshpande, Pawan K. Sharma, Mehra Haghi, Sukhwinder Singh Sohal
Publikováno v:
American Journal of Respiratory Cell and Molecular Biology. 60:541-553
Current asthma therapies fail to target airway remodeling that correlates with asthma severity driving disease progression that ultimately leads to loss of lung function. Macroautophagy (hereinafte...
Autor:
Brian G. Oliver, Karosham D. Reddy, Sandra Rutting, Melissa Baraket, Gregory G. King, Katrina O. Tonga, David G. Chapman, Dia Xenaki
Publikováno v:
ERJ Open Research
article-version (VoR) Version of Record
ERJ Open Research, Vol 7, Iss 2 (2021)
article-version (VoR) Version of Record
ERJ Open Research, Vol 7, Iss 2 (2021)
Asthma is characterised by recurrent symptoms associated with variable airflow obstruction and airway hyperresponsiveness, all of which are improved with combination inhaled corticosteroid (ICS)/long-acting β-agonist (LABA) treatment in mild-to-mode
Autor:
Kielan Darcy McAlinden, Anudeep Kota, Deepak A. Deshpande, Brian G. Oliver, Sukhwinder Singh Sohal, Mathew Suji Eapen, Pawan K. Sharma, Dia Xenaki, Howard Vindin
Publikováno v:
Clinical Science. 132:1615-1627
Increased airway smooth muscle (ASM) mass is observed in chronic obstructive pulmonary disease (COPD), which is correlated with disease severity and negatively affects lung function in these patients. Thus, there is clear unmet clinical need for find
Autor:
Monique A. Malouf, Brian G. Oliver, Dia Xenaki, Lisa Wood, Philip M. Hansbro, Sandra Rutting, Jay C. Horvat
Publikováno v:
American journal of physiology. Lung cellular and molecular physiology. 316(1)
Short-chain fatty acids (SCFAs), produced as by-products of dietary fiber metabolism by gut bacteria, have anti-inflammatory properties and could potentially be used for the treatment of inflammatory diseases, including asthma. The direct effects of
Autor:
Dia Xenaki, Brian G. Oliver, Sandra Rutting, Michael Papanicolaou, Philip M. Hansbro, Lisa Wood, Alexander M. Mullin
Publikováno v:
Respiratory Research
Respiratory Research, Vol 19, Iss 1, Pp 1-12 (2018)
Respiratory Research, Vol 19, Iss 1, Pp 1-12 (2018)
Background The obesity paradox in COPD describes protective effects of obesity on lung pathology and inflammation. However, the underlying relationships between obesity, diet and disease outcomes in COPD are not fully understood. In this study we mea
Publikováno v:
Airway Cell Biology and Immunopathology.
E-cigarettes are proposed as an alternative to smoking and as nicotine replacement therapy. There is confusion around their safety stemming from contradictory findings across multiple studies. Patients with COPD find it difficult to quit smoking and